Øresund Pharma ApS: Financial statements 2020
CVR: 39492059
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 2,754,994 and a net result of DKK -86,083 compared with DKK 2,568,553 the year before. That is a decrease of 44.1% compared with the year before. Equity in the 2020 report amounted to DKK 3,109,326. The solvency ratio was 13.5%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,754,994
- Profit/Loss
- DKK -86,083
- Equity
- DKK 3,109,326
- Total Assets
- DKK 23,025,423
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 2.8 mio. | -86 t. | 3.1 mio. | 4 |
| 2019 | - | 4.9 mio. | 2.6 mio. | 2.7 mio. | 3 |
Official annual report
How creditworthy is Øresund Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 18, 2020, Machpali ApS is registered as an owner of Øresund Pharma ApS with an ownership share of 90%.
As of December 18, 2020, ESH Holding 2019 ApS is registered as an owner of Øresund Pharma ApS with an ownership share of 10%.
Øresund Pharma ApS has published its annual report for 2019. Gross profit came to DKK 4,932,387, and the net result was DKK 2,568,553.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.